Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss of $1.13/sh

Go back to Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss of $1.13/sh
(NASDAQ: VRDN) Delayed: 21.77 -0.67 (2.99%)
Previous Close $22.44    52 Week High
Open $22.88    52 Week Low
Day High $22.97    P/E N/A 
Day Low $21.77    EPS
Volume 490,760